Table 2.
The impact of Zimbabwe’s PMTCT program implementing the 2010 WHO Option A guidelines on MTCT and HIV-free infant survival at 9–18 months
| CA-level Mean | 95% CI | p value | ||
|---|---|---|---|---|
| MTCT at 9–18 months | ||||
| Baseline estimate (CA-level aggregate) | 10.03 | 7.50 | 12.56 | |
| Endline estimate (CA-level aggregate) | 4.83 | 3.35 | 6.31 | |
| Difference: Endline - Baseline estimate | −5.19 | −8.13 | −2.26 | 0.001 |
|
| ||||
| HIV-free infant survival at 9–18 months | ||||
| Baseline estimate (CA-level aggregate) | 89.60 | 87.07 | 92.13 | |
| Endline estimate (CA-level aggregate) | 95.12 | 93.63 | 96.60 | |
| Difference: Endline - Baseline estimate | 5.51 | 2.58 | 8.45 | <0.001 |
MTCT = mother-to-child transmission of HIV; CA=catchment area
Note: Pre-post analysis with the catchment area as the unit of analysis. We calculated weighted CA-level MTCT and HIV-free infant survival at both time points and used a paired t-test to estimate the mean change in these unadjusted proportions in each CA between the 2012 survey and the 2014 survey.